Laura Hadley Buergler, DPT | |
1800 Se Moberly Ln, Bentonville, AR 72712-7017 | |
(479) 715-6330 | |
(479) 268-5144 |
Full Name | Laura Hadley Buergler |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 11 Years |
Location | 1800 Se Moberly Ln, Bentonville, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467882084 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 037558 (New York) | Secondary |
225100000X | Physical Therapist | PT3790 (Arkansas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ozark Orthopaedics, Pa | 2860477189 | 47 |
News Archive
A disposable plastic 'pop-up tent' which creates a protective barrier between patients and healthcare professionals could be the latest line of defence for frontline NHS workers thanks to a new product developed by a team from the UK.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 4 days ago
Provider Name | Aptc Of North Little Rock, Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1346245842 PECOS PAC ID: 1850298217 Enrollment ID: O20031215000820 |
News Archive
A disposable plastic 'pop-up tent' which creates a protective barrier between patients and healthcare professionals could be the latest line of defence for frontline NHS workers thanks to a new product developed by a team from the UK.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 4 days ago
Provider Name | Ozark Orthopaedics, Pa |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1649210584 PECOS PAC ID: 2860477189 Enrollment ID: O20040621001974 |
News Archive
A disposable plastic 'pop-up tent' which creates a protective barrier between patients and healthcare professionals could be the latest line of defence for frontline NHS workers thanks to a new product developed by a team from the UK.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 4 days ago
Provider Name | Aptc Of Little Rock, Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1184846701 PECOS PAC ID: 2264519891 Enrollment ID: O20080408000110 |
News Archive
A disposable plastic 'pop-up tent' which creates a protective barrier between patients and healthcare professionals could be the latest line of defence for frontline NHS workers thanks to a new product developed by a team from the UK.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Laura Hadley Buergler, DPT 1800 Se Moberly Ln, Bentonville, AR 72712-7017 Ph: (479) 715-6330 | Laura Hadley Buergler, DPT 1800 Se Moberly Ln, Bentonville, AR 72712-7017 Ph: (479) 715-6330 |
News Archive
A disposable plastic 'pop-up tent' which creates a protective barrier between patients and healthcare professionals could be the latest line of defence for frontline NHS workers thanks to a new product developed by a team from the UK.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 4 days ago
Mrs. Heidi Marie Epperson, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Tiger Blvd., Bentonville, AR 72712 Phone: 479-254-5065 Fax: 479-271-1123 | |
Ms. Tiffany Pharr Currier, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Se 22nd St, Suite 9, Bentonville, AR 72712 Phone: 479-273-9933 Fax: 479-273-9935 | |
Mrs. Leah Britt Dugal, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1601 Greenhouse Rd, Bentonville, AR 72713 Phone: 479-795-1260 | |
Chelsea Waldkirch, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1010 Nw J St Ste I, Bentonville, AR 72712 Phone: 479-440-4147 | |
Mr. Noel C. Tugwell, MPT, MS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1002 Westpark Dr, Ste 6, Bentonville, AR 72712 Phone: 479-250-4014 Fax: 479-250-4015 | |
Mr. David Logan Hill, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 908 Nw 8th Street, Bentonville, AR 72712 Phone: 479-273-1141 Fax: 479-273-3762 | |
Ashley Spencer, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712 Phone: 479-252-3321 Fax: 479-668-2257 |